| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6119921 | Journal of Clinical Virology | 2015 | 5 Pages |
Abstract
The rapid performance of a field study to evaluate WPV1 excretion unequivocally demonstrated substantial WPV1 infection rates among children under 8 years in Southern Israel, thus informing the decision to vaccinate this age group with bOPV and risk communication to both healthcare personnel and the public. Rapid development and implementation of molecular screening can thus underpin risk assessment and management in complex epidemiological situations.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Jacob Moran-Gilad, Ella Mendelson, Cara C. Burns, Ravit Bassal, Michael Gdalevich, Danit Sofer, M. Steven Oberste, Lester M. Shulman, Ehud Kaliner, Musa Hindiye, Orna Mor, Liora Shahar, Jane Iber, Ruth Yishay, Joseph Manor, Boaz Lev, Ronni Gamzu,